Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy.

Current molecular pharmacology(2023)

引用 0|浏览20
暂无评分
摘要
Based on preclinical studies, it is obvious that Res is a promising adjsuvant for CP and DOX chemotherapy, and its benefits can be utilized in the clinical course.
更多
查看译文
关键词
Resveratrol,antitumor activity,cancer chemotherapy,chemoprotection,chemoresistance,cisplatin,doxorubicin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要